Largest Disease Modification Trial For Parkinson's Disease Completes Enrollment

Sun, 24 Dec 2006 02:00 PM EST

... The largest clinical study to investigate disease modification in early Parkinson's disease (PD) has completed enrollment. The ADAGIO (Attenuation of Disease progression with AZILECT(R) GIven Once-daily) study is evaluating approximately 1,200 recently diagnosed patients worldwide to determine if treatment with once-daily AZILECT(R) (rasagiline tablets) can slow the progression of PD. [click link for full article] ...